Addressing the ‘hypoxia paradox’ in severe COVID-19: literature review and report of four cases treated with erythropoietin analogues

BACKGROUND: Since fall 2019, SARS-CoV-2 spread world-wide, causing a major pandemic with estimated ~ 220 million subjects affected as of September 2021. Severe COVID-19 is associated with multiple organ failure, particularly of lung and kidney, but also grave neuropsychiatric manifestations. Overall...

Descripción completa

Detalles Bibliográficos
Autores principales: Begemann, Martin, Gross, Oliver, Wincewicz, Dominik, Hardeland, Rüdiger, Daguano Gastaldi, Vinicius, Vieta, Eduard, Weissenborn, Karin, Miskowiak, Kamilla W., Moerer, Onnen, Ehrenreich, Hannelore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474703/
https://www.ncbi.nlm.nih.gov/pubmed/34565332
http://dx.doi.org/10.1186/s10020-021-00381-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474703/
https://www.ncbi.nlm.nih.gov/pubmed/34565332
http://dx.doi.org/10.1186/s10020-021-00381-5

Ejemplares similares